Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (14) Kammertöns, Thomas Dr. (2) Kieback, Elisa Dr. (2) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (5) Willimsky, Gerald Dr. (3) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) 2006 (1) (-) 2007 (1) (-) 2008 (1) 2010 (1) 2011 (1) 2013 (3) 2015 (2) (-) 2016 (3) 2017 (1) 2018 (3) 2020 (1) 2022 (1) Cellular Neurosciences (2) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (4) Genetics of Metabolic and Reproductive Disorders (1) Genome Engineering & Disease Models (2) Genomics (1) Immune Regulation and Cancer (3) Magnetic Resonance (4) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (5) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Transgenics (2) 5 Results: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Molecular Immunology and Gene Therapy200720082016 Sort: Result score Newest to oldest Oldest to newest May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
May 17, 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein